Engineered T cells promote long-term organ transplant acceptance
from University of Basel via EurekAlert!
Organ transplant rejection is a major problem in transplantation medicine. Suppressing the immune system to prevent organ rejection, however, opens the door to life-threatening infections. Researchers at the University of Basel's Biozentrum have now discovered a molecular approach preventing rejection of the transplanted graft while simultaneously maintaining the ability to fight against infections.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063